ChiCTR1800016097进行中（未招募）不适用
探討中度認知障礙及中度腦退化症患者及其照顧者參與優勢取向計劃後 在改善與健康相關之生活質素的成效之研究
Tung Wah Group of Hospitals1 个研究点 分布在 1 个国家目标入组 142 人开始时间: 1990年1月1日最近更新:
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 142
- 试验地点
- 1
- 主要终点
- Cognitive Function
研究概览
简要总结
探討中度認知障礙及中度腦退化症患者及其照顧者參與優勢取向計劃後 在改善與健康相關之生活質素的成效
研究设计
- 研究类型
- 干预性研究
- 主要目的
- 随机平行对照
- 盲法
- Single
入排标准
- 年龄范围
- 60 至 —（—）
- 性别
- All
入选标准
- •People with a confirmed diagnosis of MCI as indicated by a Clinical Dementia Rating Score of 0.5 or mild dementia and their primary co-residing family caregivers;
- •Able to communicate with the intervention specialist and research assistants;
- •No pre-existing acute psychotic disease;
- •Consent to participate.
排除标准
- •Subjects with psychotic disorders, unable to communicate and unable to give consent will be excluded.
研究组 & 干预措施
Two groups
Strengths-based dyadic program 1 hour per session, 1 session per week, for 9 weeks versus usual care
结局指标
主要结局
Cognitive Function
Subjective Memory
Behavioral and psychological symptoms of dementia
Depressive symptoms of caregiver
Caregiver self-efficacy
Dyadic relationship strain
Health-related quality of life
次要结局
未报告次要终点
研究者
研究点 (1)
Loading locations...
相似试验
已完成
不适用
Quality of Life and Cognitive Functioning in Patients With Glial TumorsNCT07416838Institute of Oncology Ljubljana90
尚未招募
4 期
Development of tool to assess skills and intervention guidelines to improve communication in individuals with severe speech difficulties due to Neurodevelopmental DisordersCTRI/2024/11/076110Sangeetha G S5
尚未招募
不适用
Quality of life among women with cancer cervix receiving brachytherapy as a part of treatment in a selected cancer care centre in North east India.CTRI/2025/11/096862Dr. B Borooah Cancer Institute40
尚未招募
不适用
Understanding Stroke Recovery: What Improves During Hospital Rehabilitation?CTRI/2025/12/098560All India Institute of Medical Sciences (AIIMS), Jodhpur122
招募中
2 期
Quality of life and neurocognitive functioning in diffuse low-grade glioma patients treated with Temozolomide: feasibility study - TEMOIN2024-516918-37-00Institut Regional Du Cancer De Montpellier24